ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.
The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.
This celebratory special issue reflects the wide variety of ecancermedicalscience papers published over the past ten years, and in particular the geographic heterogeneity of origin which is something of which we are particularly proud.
The papers range in topic from epidemiological factors in acute myeloid leukaemia (AML) in infants, to the history of the development of radiotherapy in Latin America, and the most clinically relevant advances in the diagnosis and treatment of non-small cell lung cancer.
Read the full editorialWatch Founding Editor Prof Gordon McVie discuss the various articles in the special issue.